neoplasm
• all mice develop acute leukemia
(J:174808)
• all other mice that do not have T-ALL develop myeloid leukemia, showing massive infiltration of leukemic blasts into the bone marrow, the spleen, and the liver, anemia, and thrombocytopenia
(J:203438)
• leukemic cells are lineage negative and c-Kit+Sca-1-CD150+, characteristic of megakaryocyte-erythroid progenitors and gene expression and binding analysis show that these leukemias show a transcriptional program similar to human acute myeloid leukemia
(J:203438)
• the Pim1 inhibitor SGI-1776 inhibits leukemia cell growth and induces apoptosis in these cells
(J:203438)
|
• approximately 30% of leukemias are characterized as T-acute lymphoblastic leukemia (T-ALL)
(J:174808)
• immunophenotype of the T-ALL blasts is cKit-CD3+CD8+CD4-
(J:174808)
• about 30% of mice develop T-ALL
(J:203438)
|
mortality/aging
• all mice that develop T-ALL die by 7 months of age with a median survival age of 20 weeks
(J:174808)
• all mice that do not develop and die from T-ALL, die from myeloid leukemia by 5 months of age
(J:203438)
|
hematopoietic system
• dense infiltration of thymus with lymphoblasts and almost complete disorganization of the tissue architecture
|
immune system
• dense infiltration of thymus with lymphoblasts and almost complete disorganization of the tissue architecture
|
endocrine/exocrine glands
• dense infiltration of thymus with lymphoblasts and almost complete disorganization of the tissue architecture
|
growth/size/body
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
acute myeloid leukemia | DOID:9119 |
OMIM:601626 |
J:203438 |